fortune ox ao vivo

The «Satanic Sisters» and Their Shared Delusion with Their Father Laura Quiñones Explores Folie à Deux in Trazos Criminales Available Every Tuesday on Audio Platforms In the latest episode of the podcast Trazos Criminales , Laura Quiñones Urquiza delves into the case of the «Satanic Sisters.» This case serves as a prime example of Folie à Deux , also known as «shared psychosis.» The story showcases how two sisters descended into a delusion involving demonological and mystical beliefs. Their case highlights the psychological power of suggestion and how it can transform ideas into dangerous actions. LISTEN TO MORE ABOUT THE «SATANIC SISTERS» BY CLICKING THE PHOTO Learn more about the «Satanic Sisters» / PHOTO: MundoNOW The case becomes even more chilling with the involvement of their father, who was subjected to a «purification ritual» driven by his daughters’ delusions. They believed that a «devil» inhabited him and that an exorcism was necessary. YOU MAY ALSO BE INTERESTED IN: UnitedHealthcare CEO Brian Thompson shot dead This incident sparked intense debate among specialists regarding the limits of suggestion, identifying it as a case of Folie à Deux . Additionally, it revealed the vulnerability of the human mind to imposed ideas. What is Folie à Deux? Folie à Deux is a rare psychiatric disorder in which a delusion is shared between two or more emotionally close individuals. This phenomenon is characterized by mutual influence between the individuals involved. While it doesn’t always result in crimes, in extreme cases, it can lead to dangerous behaviors. Its study has unveiled the complexity of psychological connections between people. The duration of Folie à Deux varies depending on the individuals and their environment. Typically, the delusion subsides when the individuals are separated, breaking their mutual influence. However, some cases leave psychological scars that are difficult to overcome. These consequences can be permanent, also impacting the social surroundings of those affected. The case of the «Satanic Sisters» is examined in-depth in Trazos Criminales , hosted by Laura Quiñones Urquiza, an expert in criminal profiling. In each episode, Quiñones explores the darkest corners of the human mind. Through her analysis, she reveals how forensic science experts solve complex cases. These cases often defy logic and common understanding. The fascination with such cases, like the «Satanic Sisters,» goes beyond their macabre nature, teaching us about the human mind and the influence of our surroundings. They also serve as warnings about the dangers of unchecked ideas. Trazos Criminales is released every Tuesday on major audio platforms. Listen to impactful stories about how forensic science unravels the darkest enigmas of our society. LISTEN TO MORE STORIES BY CLICKING THE PHOTO Learn more about the «Satanic Sisters» / PHOTO: MundoNOW if(typeof custom_paginate == "function")custom_paginate()U.S. stocks closed at more records after Donald Trump’s latest talk about tariffs created only some ripples on Wall Street. The S&P 500 rose 0.6% to reach another all-time high. The Dow Jones Industrial Average added 0.3% to its own record set the day before, while the Nasdaq composite rose 0.6% as Big Tech stocks helped lead the way. Stock markets abroad saw mostly modest losses, after President-elect Trump said he plans to impose sweeping tariffs on Mexico, Canada and China as soon as he takes office. U.S. automakers and other companies that could be hurt particularly by such tariffs fell. On Tuesday: The S&P 500 rose 34.26 points, or 0.6%, to 6,021.63. The Dow Jones Industrial Average rose 123.74 points, or 0.3%, to 44,860.31. The Nasdaq composite rose 119.46 points, or 0.6%, to 19,174.30. The Russell 2000 index of smaller companies fell 17.72 points, or 0.7%, to 2,424.31. For the week: The S&P 500 is up 52.29 points, or 0.9%. The Dow is up 563.80 points, or 1.3%. The Nasdaq is up 170.65 points, or 0.9%. The Russell 2000 is up 17.64 points, or 0.7%. For the year: The S&P 500 is up 1,251.80 points, or 26.2%. The Dow is up 7,170.77 points, or 19%. The Nasdaq is up 4,162.95 points, or 27.7%. The Russell 2000 is up 397.23 points, or 19.6%.Houston Democrat wants to remove restrictive timeline for child sexual abuse survivors

Households could face double-digit council tax hikes to fund services when current freeze on bills ends in spring Click here to visit the Scotland home page for the latest news and sport By TOM GORDON DEPUTY SCOTTISH POLITICAL EDITOR Published: 22:50, 8 December 2024 | Updated: 22:50, 8 December 2024 e-mail 1 View comments Families face costly tax rises after the finance chief for Scots councils refused to rule out double-digit increases when the current freeze ends this spring. Katie Hagmann, resources spokeswoman for council umbrella body Cosla, said ‘difficult decisions’ lay ahead, with hikes needed to keep services running. SNP Finance Secretary Shona Robison last week said there was ‘no reason’ for big tax rises after she raised council funding by £1billion to £15billion in her 2025-26 budget. But Cllr Hagmann said the real terms increase was barely half what councils asked for, as authorities needed to make up for years and years of cuts. In comments that raise the prospect of costly increases, she told BBC Scotland’s Sunday Show that more money than councils got in the Budget was required. She said: ‘It’s fair to say that there’s still going to be difficult decisions that some councils are going to have to make. ‘We asked for an increase of 5 per cent and we have had a real terms increase. However, it’s only 2.6 per cent. So while this is really welcome news, we’re not out of the woods yet.’ The SNP has frozen or capped council tax in all but two of its 17 years in office. When councils had free rein in 2022-23 and 2023-24, the average rises were 3 and 5 per cent. Finance minister Shona Robison delivering the Scottish budget on Wednesday Former first minister Humza Yousaf froze it again this year, but next year councils can set what they like again. Last week, Perth and Kinross Council approved provisional plans for a rise of 10 per cent on bills next year - then 10 per cent and 6 per cent in the years after that. Shetlands Islands Council is also consulting on a hike of up to 10 per cent next year, while Aberdeenshire has asked residents about a possible 20 per cent rise. Cosla, which represents Scotland’s 32 local authorities, recently said local government was close to a ‘tipping point’ because of stretched resources. It has demanded a £694million, or 5 per cent, increase in revenue funding to £14.5billion in 2025-26 and a £163million, or 23 per cent rise, in capital funding to £872million, to adjust for soaring inflation since 2020. Cllr Hagmann, an SNP member of Dumfries & Galloway Council, went on: ‘We do have concerns, and we would like additional funding for delivery of health and social care.’ Inadequate funding meant cuts, she said, or ‘council tax is one lever that we can use to safeguard services - council tax increases could be used to fund services locally’. Pressed on whether double-digit rises were realistic, she did not deny it. She said: ‘This is the first time that we’ve had a real terms increase for a number of years. There’s been significant cuts throughout the previous years. Click here to visit the Scotland home page for the latest news and sport Advertisement ‘That will be down to local councils. Our ask had been heard by Scottish Government for no council tax freeze and no cap. It’s not going to be easy. But the very last thing we want to do is to add the pressures onto families, onto our communities, who may already be struggling.’ She said Scotland’s 32 councils would have a better idea of what they faced when they got their individual funding figures later this week. Meanwhile, Russell Findlay told the programme Scotland’s benefits bill - set to rise from £6.9 billion to £8.8 billion by 2030 and already running £1.3 billion ahead of Treasury funding - was ‘unsustainable’. The Scottish Tory leader said: ‘We can’t continue to increase benefits and increase taxes. The entire benefits bill needs to be looked at.’ Citing the budget decision to restore free bus travel for asylum seekers for £2million, he said: ‘That money would pay for the winter fuel payment for 6,000 Scottish pensioners who are in desperate need of it - that’s a much better way of spending that money. ‘This ever increasing benefits bill is unsustainable. It’s unaffordable. It lacks basic common sense. It can’t continue down this path.’ Ms Robison said some devolved benefits helped children out of poverty, benefitting society and reducing demand for public services down the line. She denied the Scottish public sector was ‘bloated’ but added: ‘Does it need to be more efficient and productive? Does it need to change and reform? Yes.’ Humza Yousaf Scotland Taxes SNP Share or comment on this article: Households could face double-digit council tax hikes to fund services when current freeze on bills ends in spring e-mail Add comment

ATLANTIC CITY, N.J. (AP) — New Jersey gambling regulators have handed out $40,000 in fines to two sportsbooks and a tech company for violations that included taking bets on unauthorized events, and on games that had already ended. In information made public Monday, the New Jersey Division of Gaming Enforcement fined DraftKings $20,000. It also levied $10,000 fines on Rush Street Interactive NJ and the sports betting technology company Kambi. Javascript is required for you to be able to read premium content. Please enable it in your browser settings.

Our community members are treated to special offers, promotions and adverts from us and our partners. You can check out at any time. More info Some Nationwide account holders could be in line to receive a new £100 bonus, the bank have announced. The welcome boost could be delivered to some customers if they meet certain criteria. The building society said: "As a modern mutual we are able to share some of our profits with members who bank and borrow or who bank and save with us. We will do this by making a one-off payment of £100 to those who qualify. We have called this the Nationwide Fairer Share Payment." The Mirror reports that eligible customers must own one of a qualifying current account, qualifying savings account or a qualifying mortgage. To be qualifying current account, your account must have been open on March 31 and any additional requirements depend on the type of current account you had on that date. The FlexAccount, FlexDirect or FlexBasic are also eligible under the follow conditions. One of these requirements must be met. Either in two of of the three months of January, February and March 2024 you received at least £500 in your current account or made at least two payments out of your current account. Or, in two of those three months you have made at least 10 payments out of the account. Nationwide says a savings account holder will qualify for the bonus if they had at least £100 in total in one or more personal savings accounts or crash ISAs, with Nationwide at the end of any day in March 2024. These do not include money held in your savings accounts, money or other assets in an investment accounts such as stocks and shares, or money in an account in the name of someone else. A qualifying mortgage means you must have owed the baking society at least £100 on your residential mortgage on March 31. It does not include a mortgage with one of the bank's subsidiaries such as The Mortgage Works (UK) plc, UCB Home Loans Corporation Limited, Derbyshire Home Loans Limited, or E-Mex Home Funding Limited. A mortgage which was applied for but wasn't completed by March 31, as well as Nationwide commercial mortgages are not eligible. For those who have a joint account , Nationwide says the terms and conditions apply to each person individually. The bank explained: "This means that if a qualifying current account, or qualifying mortgage is in joint names, the product and the whole of any balance will count towards each individual’s eligibility for the payment. "For example, if you hold both a qualifying current account and a qualifying mortgage jointly with someone else, you will both be eligible to receive the payment. Similarly, qualifying savings will take account of the whole of any savings and cash ISA balances you hold in your sole name and those you hold jointly." Get the latest news sent straight to your messages by joining our WhatsApp community today. You'll receive daily updates on breaking news as well as the top headlines across Scotland. No one will be able to see who is signed up and no one can send messages except the Daily Record team. All you have to do is click here if you're on mobile , select 'Join Community' and you're in! If you're on a desktop, simply scan the QR code above with your phone and click 'Join Community'. We also treat our community members to special offers, promotions, and adverts from us and our partners. If you don’t like our community, you can check out any time you like. To leave our community click on the name at the top of your screen and choose 'exit group'. If you’re curious, you can read our Privacy Notice. Those who are running an account for others that are in someone else's name - under a power of attorney, third-party mandate or court order for example - won't be qualify for the bonus. As a result, the money and any savings won't qualify towards savings for you, but will for the person whose name the account is in. Nationwide has said it plans to make payments to members between June 13 and June 28 next year. The bank says: "We will pay the money into your Nationwide current account. If you hold more than one current account with us, we may pay the money into any of those accounts. "We will pay the money into an account in your sole name if you have one and will pay it into a joint account if you do not. The payment will appear on your current account statement as Nationwide Fairer Share Payment." A spokesman added: "We always do our best to ensure that the information is accurate and complete, but incomplete, inaccurate, or out of date information may mean we wrongly exclude you from the payment. We will make the payment if we find out you were wrongly excluded, but we will not be liable for any other loss you may incur if this happens. "We also cannot guarantee how quickly an application for a qualifying product might be completed and therefore will not be responsible if you miss out on the payment because of a delay in opening a relevant product. If, after checking your eligibility, you think you have been wrongly excluded, please get in touch and if we have got it wrong, we will take steps to put it right."None

Tesco plans to open 150 new convenience stores creating 2,000 new jobsFulcrum Therapeutics to Participate in Upcoming December Conferences

Minnesota hunters registered 120,675 deer after the third weekend of the firearms deer season, up 6% from 2023, but down 4% from the five-year mean, or average, the Department of Natural Resources reported Tuesday, Nov. 26. Deer Season A opened Saturday, Nov. 9, and ended Nov. 17 in 200- and 300-series deer permit areas (DPAs) and continued through Nov. 24 in 100-series DPAs, which are mainly in the northern and northeastern part of the state. ADVERTISEMENT The Season B firearms deer season in 300-series DPAs opened Nov. 23 and continues through Sunday, Dec. 1. The firearms deer harvest by region after 16 days was as follows: According to Todd Froberg, big game program coordinator for the DNR at Whitewater Wildlife Management Area in Altura, Minnesota, the harvest really only increased in the Northwest, Northeast and Central regions during the rest of the 16-day season and then in the B season in the southeast part of the state. The 200-series DPAs only had the nine-day season, and there is only one DPA in the southwest region open during the ongoing B season, Froberg said. The cumulative harvest to date, which includes archery, firearm, early antlerless, youth and special hunts, was 153,390 deer, the DNR said. That’s up 3% from 2023, but down 6% from the five-year average and down 8% from the 10-year average. Cumulative tallies by region were as follows: In related deer hunting news, Minnesota archery hunters as of Tuesday had harvested 23,047 deer, Froberg said, up 12% from last year. Crossbows, which are legal for all archery hunters in Minnesota, are making up a greater percentage of the archery harvest, Froberg says. ADVERTISEMENT “Crossbows are making up 47% of (the) archery harvest,” he said. “For crossbow-specific harvest, we are up 24% compared to last year’s crossbow harvest. Vertical bow harvest is up 4% compared to last year’s vertical bow harvest.” Minnesota’s muzzleloader opens Saturday, Nov. 30, and continues through Sunday, Dec. 15. Archery season continues through Dec. 31. The DNR posts regular harvest updates, both statewide and by DPA, on its website at dnr.state.mn.us/mammals/deer/management/statistics.html.

Randy Moss announces cancer battle, says he has undergone successful surgeryPhillies have no plans to start pitching prospect Andrew Painter in spring training following injury

Minnesota hunters registered 120,675 deer after the third weekend of the firearms deer season, up 6% from 2023, but down 4% from the five-year mean, or average, the Department of Natural Resources reported Tuesday, Nov. 26. Deer Season A opened Saturday, Nov. 9, and ended Nov. 17 in 200- and 300-series deer permit areas (DPAs) and continued through Nov. 24 in 100-series DPAs, which are mainly in the northern and northeastern part of the state. ADVERTISEMENT The Season B firearms deer season in 300-series DPAs opened Nov. 23 and continues through Sunday, Dec. 1. The firearms deer harvest by region after 16 days was as follows: According to Todd Froberg, big game program coordinator for the DNR at Whitewater Wildlife Management Area in Altura, Minnesota, the harvest really only increased in the Northwest, Northeast and Central regions during the rest of the 16-day season and then in the B season in the southeast part of the state. The 200-series DPAs only had the nine-day season, and there is only one DPA in the southwest region open during the ongoing B season, Froberg said. The cumulative harvest to date, which includes archery, firearm, early antlerless, youth and special hunts, was 153,390 deer, the DNR said. That’s up 3% from 2023, but down 6% from the five-year average and down 8% from the 10-year average. Cumulative tallies by region were as follows: In related deer hunting news, Minnesota archery hunters as of Tuesday had harvested 23,047 deer, Froberg said, up 12% from last year. Crossbows, which are legal for all archery hunters in Minnesota, are making up a greater percentage of the archery harvest, Froberg says. ADVERTISEMENT “Crossbows are making up 47% of (the) archery harvest,” he said. “For crossbow-specific harvest, we are up 24% compared to last year’s crossbow harvest. Vertical bow harvest is up 4% compared to last year’s vertical bow harvest.” Minnesota’s muzzleloader opens Saturday, Nov. 30, and continues through Sunday, Dec. 15. Archery season continues through Dec. 31. The DNR posts regular harvest updates, both statewide and by DPA, on its website at dnr.state.mn.us/mammals/deer/management/statistics.html.

Iraqi story repeats in SyriaCanoeist grateful for life paddling 6,000-mile loop

(BPT) - Tech gifts are consistently some of the most popular presents to give and receive during the holidays. In fact, according to the annual Consumer Technology Holiday Purchase Patterns report , a record 233 million U.S. adults (89%) will buy tech products during the 2024 holiday season. But with so many devices out there, it can be hard to decide on the perfect option for the loved one on your list. Javascript is required for you to be able to read premium content. Please enable it in your browser settings.

750,000 Sign Petition Calling For General Election in Britain as Labour Party Support FadesAttack On Dharmasala MLA In Odisha: BJD, BJP Trade Charges Over Police Action

Diffuse Large B-cell Lymphoma | Image Credit: © Свет Лана – stock.adobe.com Data from a retrospective medical chart review shared during the 2024 ASH Annual Meeting confirmed the real-world effectiveness of tafasitamab-cxix (Monjuvi) use in US patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and shed light on certain factors associated with survival. 1 At a median follow-up time of 14.7 months (range, 8.5-17.1) from tafasitamab initiation, the real-world progression-free survival (PFS) with tafasitamab was 11.3 months (95% CI, 9.8-13.6) in the overall population (n = 181), and the real-world overall survival (OS) was 24.8 months (95% CI, 17.8-not evaluable [NE]). The real-world overall response rate (ORR) to the agent was 73.5%, which comprised a complete response (CR) rate of 23.2% and a partial response (PR) rate of 50.3%. In the patients who achieved a real-world CR or PR with the agent (n = 133), the real-world duration of response (DOR) was 9.6 months (95% CI, 8.3-13.3). A multivariable analysis showed that factors significantly linked with increased risk of progression included receiving the agent in the third to fifth line (n = 51) vs the second line (n = 130; HR, 1.79; 95% CI, 1.20-2.66; P = .004), having Ann Arbor stage III to IV disease (n = 169) vs stage I to II (n = 10; HR, 0.30; 95% CI, 0.10-0.95; P = .041), increasing Charlson Comorbidity Index scores (n = 181; HR, 1.43; 95% CI, 1.03-1.97; P = .033), and bulky (n = 36) vs non-bulky (n = 145) disease (HR, 1.96; 95% CI, 1.26-3.05; P = .003). To overcome violation of proportional hazards assumption caused by the variable of ECOG performance status, coefficients had been adjusted for status of 2 or higher vs under 2 through stratifying the model on performance status. Moreover, a cox proportional hazards model showed that factors significantly associated with increased risk of mortality included receiving tafasitamab in the third to fifth line vs the second line (HR, 2.39; 95% CI, 1.46-3.93; P < .001), increasing age (HR, 1.06; 95% CI, 1.03-1.09; P < .001), ECOG performance status of 2 or higher (n = 86) vs below 2 (n = 95; HR, 3.57; 95% CI, 2.13-5.97; P < .001), and bulky vs non-bulky disease (HR, 2.22; 95% CI, 1.27-3.87; P = .005). “The additional follow-up from the initial data collection allowed for a more robust evaluation of the real-world effectiveness of tafasitamab in patients with relapsed or refractory DLBCL, predominantly in the community practice setting,” lead study author Kim Saverno, PhD, of Incyte Corporation, in Wilmington, Delaware, said in a poster presentation of the data. “These results support a real-world clinical benefit for tafasitamab, with the greatest benefit observed when [the agent] was received in second vs later lines of therapy.” The CD19-targeted immunotherapy, tafasitamab, was approved by the FDA in July 2020 for use in combination with lenalidomide (Revlimid) in adult patients with relapsed or refractory DLBCL not otherwise specified, including DLBCL arising from low-grade lymphoma, and who are not candidates to undergo autologous stem cell transplant. 2 To date, few studies have evaluated the agent in a US real-world setting, according to Saverno. 1 She added that data from a real-world study were previously shared, but had a limited follow-up time of 6.5 months, which “precluded robust evaluations of the clinical effectiveness” of the agent. 3 For the current retrospective, multisite, medical chart review, 23 physicians from Cardinal Health’s Oncology Provider Extended Network abstracted data from 181 eligible patients’ medical records into electronic case report forms. Notably, 83% of these physicians practiced in the community. 1 For patients to be considered eligible for the analysis, they must have started treatment with tafasitamab with or without concomitant lenalidomide for relapsed/refractory disease on or following October 21, 2020; be at least 18 years old at the time treatment with the agent was started; and have undergone at least 4 months of follow-up since treatment started. Those who died during this 4-month interval were still permitted. If patients received the agent as part of an interventional clinical trial, they were excluded. A total of 182 patients met the prespecified eligibility criteria; 1 patient who received tafasitamab only as bridge therapy to CAR T-cell therapy was excluded. As such, a total of 181 patients were included in the study; 144 of these patients were still alive at last follow-up of initial data collection which had occurred between February 22, 2023, and March 29, 2023. Of those patients, 137 patients had additional follow-up data available and underwent additional data collection between December 18, 2023, and January 31, 2024. A total of 106 patients were alive at last follow-up. “Data collected at the two time points were merged and descriptive statistics were used to summarize the results,” Saverno explained. “Kaplan-Meier analyses were used to calculate time-to-event end points and multivariable Cox analyses were used to assess factors associated with real-world PFS and OS.” In the 181 total patients, the median age at the time of tafasitamab initiation was 71.1 years (range, 65.0-75.5). Most patients were White (64.1%), and more than half of patients were male (56.4%). Regarding Ann Arbor stage at time of treatment initiation, 5.5% had stage I or II disease, 93.4% had stage III or IV disease; this information was unknown for 1.1% of patients. ECOG performance status at the time of treatment initiation was 0 to 1 for 52.5% of patients and 2 or higher for 47.5% of patients. Revised International Prognostic Index for Diffuse Large B-cell Lymphoma was 3 to 5 for 80.5% of patients and 1 to 2 for 19.5% of patients. “Over 70% of patients received tafasitamab in the second line, and 71% of patients had discontinued tafasitamab at the last follow-up, mostly due to disease progression,” Saverno noted. “Over half of the patients were still alive at the last follow-up, and among the patients still alive, half [were] still receiving tafasitamab at the time of the most recent follow-up.” Additional treatment outcome data showed that in those who received tafasitamab in the second line (n = 130), the real-world ORR was 78.5%; this was comprised of a CR rate of 27.7% and a PR rate of 50.8%. For this group, the stable disease (SD) rate was 8.5%, the progressive disease (PD) rate was also 8.5%, and 4.6% of patients did not have these data available. In the group of patients who received the immunotherapy in the third line (n = 43), the real-world ORR was 62.8%; this comprised a CR rate of 11.6% and a PR rate of 51.2%. In this subset, the SD and PD rates were 18.6% and 11.6%, respectively; 7.0% of patients did not have these data available. In patients who experienced a real-world CR as a best response to tafasitamab (n = 42), the median real-world DOR was 19.2 months (95% CI, 8.8-NE). In those who achieved a real-world PR as a best response to the agent (n = 91), the median real-world DOR was 8.5 months (95% CI, 6.8-10.0). “This study is impacted by limitations inherent to real-world studies, such as unobserved and missing data,” Saverno concluded. “The number of participating oncologists was small and thus may not reflect the treatment patterns of all US oncologists managing patients with DLBCL.” Disclosures: Dr Saverno cited employment and stock ownership with Incyte Corporation.